CD1D and melanoma: We provide further evidence that epigenetic changes in the TME of melanoma tumors have a direct impact on B2M and an indirect impact on CD1D gene expression (through SPI1) but not on CD1B and FCGRT expression in melanoma patients from the TCGA dataset.